In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors

BACKGROUND: Cefiderocol demonstrates excellent activity against MDR Pseudomonas aeruginosa; however, the activity against isolates from patients previously treated with β-lactam agents is unknown. We aimed to determine the activity of cefiderocol against P. aeruginosa collected before and after trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Ryan K, Kline, Ellen G, Squires, Kevin M, Van Tyne, Daria, Doi, Yohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546814/
https://www.ncbi.nlm.nih.gov/pubmed/37795425
http://dx.doi.org/10.1093/jacamr/dlad107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546814/
https://www.ncbi.nlm.nih.gov/pubmed/37795425
http://dx.doi.org/10.1093/jacamr/dlad107

Ejemplares similares